Form 8-K - Current report:
SEC Accession No. 0001683168-26-004956
Filing Date
2026-06-18
Accepted
2026-06-18 09:19:55
Documents
11
Period of Report
2026-06-17
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT valion_8k.htm   iXBRL 8-K 28824
  Complete submission text file 0001683168-26-004956.txt   193233

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE vbio-20260617.xsd EX-101.SCH 2990
3 XBRL LABEL FILE vbio-20260617_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE vbio-20260617_pre.xml EX-101.PRE 22342
14 EXTRACTED XBRL INSTANCE DOCUMENT valion_8k_htm.xml XML 3206
Mailing Address 1305 E. HOUSTON STREET BUILDING 1, SUITE 311 SAN ANTONIO TX 78205
Business Address 1305 E. HOUSTON STREET BUILDING 1, SUITE 311 SAN ANTONIO TX 78205 (888)276-6888
Valion Bio, Inc. (Filer) CIK: 0001787740 (see all company filings)

EIN.: 814016391 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41052 | Film No.: 261100614
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)